PSY33 Clinical and Economic Analysis of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura in Context of Russian Health Care System

The emergence of new drugs for the treatment of patients with chronic idiopathic thrombocytopenic purpura (ITP), stimulates the proliferation of megakaryocyte germ (eltrombopag), stresses the need to conduct a comparative analysis in their cost-effectiveness, compared with other modern treatment options. Markov modeling was used. Markov model, developed by GlaxoSmithKline, was adapted to the context of Russian health care system to assess...